Cielo Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 55.65%
- Profit Growth 60.02%
- Ebitda 26.91%
- Net Worth 366.37%
- Total Assets 28.94%
About Cielo Biotech
Cielo Biotech Private Limited (CBPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 November 2014 and has a history of Ten years and three months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vinay Devabhakthuni, Fred Ananth, and Razia Gajendrababu serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909TN2014PTC098130
- Company No.
098130
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Nov 2014
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Cielo Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinay Devabhakthuni  | Director | 20-Nov-2014 | Current |
| Fred Ananth | Director | 20-Nov-2014 | Current |
| Razia Gajendrababu | Director | 01-Mar-2019 | Current |
Financial Performance of Cielo Biotech.
Cielo Biotech Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 55.65% increase. The company also saw a substantial improvement in profitability, with a 60.02% increase in profit. The company's net worth Soared by an impressive increase of 366.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cielo Biotech?
In 2020, Cielo Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Quatrade LlpVinay Devabhakthuni is a mutual person
- Ramaratnam Trading (Opc) Private Limited
Vinay Devabhakthuni is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cielo Biotech?
Unlock and access historical data on people associated with Cielo Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cielo Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cielo Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.